Can artificial intelligence provide a real medical breakthrough? Let’s find out.

Undoubtedly, there is a massive innovation in technology whether it be, the Edison’s light bulbs, steam engine, PC or smartphones, these innovations have continued changing the world in extremely new ways. Particularly, there is an upward curve in the artificial intelligence (AI) systems that is expected to be a game changer in most industries. AI progress with the human innovation and has further extended its wings in the medical industry in search of detecting cancer cells and finding a possible cure.

Researchers and experts from all over the world believe that AI cancer cure is not far and the path towards getting a complete cure for cancer involves small progressions, just like past technological innovations that has led to advanced technologies.

advanced technologies

A report by Frost & Sullivan indicates that the market cap for AI is expected to hit $6 billion by 2021. For this reason, healthcare institutions around the world are investing a lot to get into this new technology to increase their efficiency in treatment methods and get ahead with cancer diagnosis. Another reason for such a move is the recent developing need is to increase value in health care which have led to a massive campaign to have affordable health care across the world.

Read More: – The Importance of Artificial Intelligence To Humans

Since the process involves small iterations to solve the problems progressively, it is expected that AI technology will provide a perfect ground for contributors who want to take part in this huge challenge.

Research on Vexing Issues

Vexing Issues

A myriad of research have been done on AI while others are underway.

Earlier this year, Microsoft launched Healthcare NExT. It’s an initiative that aims to combine AI, health research, and the knowledge of other industry players to come up with an effective way to provide people with alternative that may lead to healthy life free from dangerous diseases. Although it’s quite a challenge, Peter Lee, Corporate Vice President of this project believes that a combination of AI and cloud will be the first step in transforming the healthcare industry.

Google has embarked on a worldwide campaign to expand Healthcare NExT initiative on cancer research. It’s motto is to accelerate the process to find a reliable cure and effective treatment for cancer. It’s designed to apply artificial intelligence and machine-learning technologies on health matters including cancer treatment. It means that Microsoft will use the idea that cancer cells can be reprogrammed just like an electronic device instead of being destroyed, then deleted instead of being killed.

In Silicon Valley, which is home to world’s leading problem-solving ideas, experts have also contributed towards finding an accelerated cure for cancer, diabetes, and other major health illnesses. For instance, one of the initiatives by Silicon Valley Company known as Nvidia has made major strides in finding a cancer cure. Nvidia has recently joined hands with the U.S Department of Energy, National Cancer Institute, and several other healthcare provides on the pursuit to accelerate cancer cure research. In this case, they focus on developing an AI framework known as CANDLE that utilizes AI technology to fight cancer cells. CANDLE will be the first of its kind, built on AI system to be a powerful tool to enable experts work towards finding a cure for this disease.

Nvidia claims to have high tech graphic processors in place to power up world’s fastest supercomputers. These devices can handle multiple transactions per second and use AI to mine data and try to find possible answers to huge problems. Similarly, Watson has joined in the league of cancer cure hunt in partnership with other Veteran companies to provide even more powerful supercomputers to power up some of the biggest data projects in the world.

Read More: – 8 Different Ways Chatbots Are Helping Businesses Grow

John Sculley, Zeta Global co-founder has teamed up with the Company’s CEO, David Steinberg to contribute on AI usefulness in the future technological advancement. They have indicated that the artificial intelligence framework enables most institutions and companies to join the movement. It’s about creating a program that can be updated with developing information to help get real answers within a short time.

These development reflect the status quo in the artificial intelligence world. In this case, it’s all about use of cognitive engines to perfect repetitive tasks and examine a large number of tissue samples to detect any signs of cancer cells. The most advanced AI technologies have already started using these engines including Apple with the face-recognition feature that controls the Face Identity authentication of the iPhone X. A similar case is an object-recognition technology used to power Deep Lens Video camera by Amazon. These tools are referred to as 1x AL transformations that play a key role in satisfying instant needs for a specific objective. These types of innovations are expected to give way to the second generation of more advanced transformations that will take things a notch higher in finding a cure for cancerous cells.

Future Ambition for the Cancer Cure

Discovering an effective cancer cure will take time, but the interesting part is that cancer research has improved with the involvement of advanced technology and involvement of more powerful companies. The road to the cure will progress with AI technology. To be part of the complex process, providers and experts of AI technology will have to go through the iterative process of AI framework that is made up of small progress towards the cancer cure.

Most companies are optimistic to make an impact in healthcare and most have invested a lot in AI technology. So, it’s evident that artificial intelligence is not only concentrated in fields such as entertainment, space research, etc. but it has also hit the health sector to a great extent. It is expected that AI will certainly lead to an effective long-term solution for cancer patients.